Researchers deploy CRISPR to develop faster mpox testing

26504_lores

Source: CDC/ National Institute of Allergy and Infectious Diseases (NIAID)

Using gene editing proteins combined with nanopore sensing technology, new research shows that testing for pathogens could become faster and more accessible.

 Registered users, subscribers or members - SIGN IN

To continue reading this article

Membership

Included as a benefit

Members of Applied Microbiology International have unlimited access to The Microbiologist as a benefit of membership. Just sign in with your usual membership credentials.

I AM A MEMBER

Find out more about how to join.

 

Register

FREE

Want to read more before deciding on a subscription? It only takes a minute to sign up for a free account and you’ll get to enjoy more free content each month.

REGISTER

 

Subscribe

3.75 per month / £35 annually

Get unlimited access to The Microbiologist.

SUBSCRIBE